Clinical Trial Update: A Study of Naldemedine (S-297995) for the Treatment of Opioid-Induced Constipation in Adults With Non-Malignant Chronic Pain Receiving Opioid Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial results for Naldemedine (S-297995) in adults with opioid-induced constipation due to non-malignant chronic pain on opioid therapy have been posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation

Drugs mentioned

• SYMPROIC (NALDEMEDINE)

Snippet

Sponsor: Shionogi | Conditions: Opioid-induced Constipation | Phase 2 | Status: COMPLETED | Results posted: 2017-05-30